title: General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints.
abstract: LC coupled to single (LC-MS) and tandem (LC-MS/MS) mass spectrometry is recognized as the most powerful analytical tools for metabolic studies in drug discovery. In this article, we describe five cases illustrating the utility of screening xenobiotic metabolites in routine analysis of forensic samples using LC-MS/MS. Analyses were performed using a previously published LC-MS/MS general unknown screening (GUS) procedure developed using a hybrid linear IT-tandem mass spectrometer. In each of the cases presented, the presence of metabolites of xenobiotics was suspected after analyzing urine samples. In two cases, the parent drug was also detected and the metabolites were merely useful to confirm drug intake, but in three other cases, metabolite detection was of actual forensic interest. The presented results indicate that: (i) the GUS procedure developed is useful to detect a large variety of drug metabolites, which would have been hardly detected using targeted methods in the context of clinical or forensic toxicology; (ii) metabolite structure can generally be inferred from their "enhanced" product ion scan spectra; and (iii) structure confirmation can be achieved through in vitro metabolic experiments or through the analysis of urine samples from individuals taking the parent drug.
authors.affiliation: CHU Limoges, Department of Pharmacology-Toxicology, Limoges, France.
authors.forename: François-Ludovic
authors.initials: FL
authors.lastname: Sauvage
authors.forename: Nicolas
authors.initials: N
authors.lastname: Picard
authors.forename: Franck
authors.initials: F
authors.lastname: Saint-Marcoux
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Gaulier
authors.forename: Gérard
authors.initials: G
authors.lastname: Lachâtre
authors.forename: Pierre
authors.initials: P
authors.lastname: Marquet
mesh_terms: D002851:Chromatography, High Pressure Liquid; D003987:Dibenzothiazepines / Q000378:metabolism / Q000652:urine*; D055808:Drug Discovery; D053593:Forensic Toxicology; D006801:Humans; D009665:Noscapine / Q000378:metabolism / Q000652:urine*; D010078:Oxazines / Q000378:metabolism / Q000652:urine*; D011222:Prazepam / Q000378:metabolism / Q000652:urine*; D000069348:Quetiapine Fumarate; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry; D014196:Trazodone / Q000378:metabolism / Q000652:urine*
chemical_list: D003987:Dibenzothiazepines; D010078:Oxazines; D000069348:Quetiapine Fumarate; D009665:Noscapine; D011222:Prazepam; C002125:etifoxine; D014196:Trazodone